Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Key Metrics
as of Sep 2026
Market Cap 15,886 Cr
P/E 21.30
Div Yield 1.48 %
Book Value βΉ289.00
52w High βΉ998.00
52w Low βΉ635.00
Face Value βΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
1,868.00
1,719.00
1,642.00
1,796.00
1,494.00
1,571.00
1,406.00
1,580.00
1,476.00
1,475.00
1,588.00
1,479.00
1,332.00
Expenses
1,522.00
1,445.00
1,371.00
1,493.00
1,280.00
1,400.00
1,226.00
1,321.00
1,184.00
1,186.00
1,251.00
1,271.00
1,167.00
Operating Profit
346.00
274.00
272.00
303.00
214.00
171.00
180.00
259.00
291.00
288.00
337.00
207.00
166.00
OPM %
19.00
16.00
17.00
17.00
14.00
11.00
13.00
16.00
20.00
20.00
21.00
14.00
12.00
Other Income
14.00
1.00
-32.00
11.00
8.00
13.00
15.00
29.00
3.00
7.00
3.00
9.00
12.00
Depreciation
83.00
82.00
80.00
76.00
73.00
69.00
70.00
70.00
69.00
69.00
69.00
67.00
66.00
Interest
21.00
19.00
22.00
23.00
23.00
24.00
22.00
18.00
13.00
10.00
15.00
15.00
14.00
Profit before tax
256.00
173.00
139.00
216.00
126.00
92.00
104.00
200.00
213.00
216.00
257.00
134.00
98.00
Tax %
23.00
-40.00
18.00
17.00
18.00
18.00
17.00
17.00
17.00
7.00
9.00
0.00
0.00
Net Profit
197.00
243.00
114.00
179.00
104.00
75.00
86.00
166.00
176.00
202.00
233.00
134.00
98.00
EPS in Rs
10.02
12.37
5.82
9.12
5.27
3.83
4.37
8.43
8.96
10.27
11.87
6.81
4.96
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
6,651.00 6,033.00 5,874.00 5,149.00 5,035.00 5,067.00 4,133.00 3,660.00 2,945.00 2,986.00 3,009.00 2,019.00
Expenses
5,586.00 5,131.00 4,875.00 4,484.00 4,127.00 3,618.00 2,930.00 2,782.00 2,313.00 2,353.00 2,026.00 1,611.00
Operating Profit
1,065.00 901.00 999.00 665.00 909.00 1,449.00 1,203.00 879.00 633.00 633.00 983.00 408.00
OPM %
16.00 15.00 17.00 13.00 18.00 29.00 29.00 24.00 21.00 21.00 33.00 20.00
Other Income
-13.00 61.00 31.00 3.00 51.00 84.00 125.00 6.00 7.00 3.00 7.00 3.00
Interest
87.00 76.00 54.00 49.00 17.00 13.00 25.00 15.00 2.00 3.00 4.00 3.00
Depreciation
311.00 277.00 271.00 273.00 285.00 183.00 136.00 106.00 102.00 83.00 72.00 44.00
Profit before tax
654.00 609.00 704.00 346.00 658.00 1,338.00 1,167.00 765.00 535.00 550.00 914.00 363.00
Tax %
2.00 17.00 5.00 0.00 17.00 18.00 17.00 20.00 21.00 22.00 24.00 21.00
Net Profit
640.00 503.00 666.00 347.00 544.00 1,097.00 969.00 611.00 422.00 431.00 699.00 287.00
EPS in Rs
32.58 25.60 33.91 17.64 27.65 55.79 51.42 32.42 22.38 22.84 37.06 15.20
Dividend Payout %
37.00 43.00 32.00 45.00 36.00 25.00 19.00 17.00 18.00 18.00 11.00 23.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
39.00 39.00 39.00 39.00 39.00 39.00 38.00 38.00 38.00 38.00 38.00 38.00
Reserves
5,576.00 5,155.00 4,870.00 4,375.00 5,251.00 5,062.00 3,308.00 2,675.00 2,157.00 1,830.00 1,493.00 796.00
Borrowings
1,198.00 1,194.00 492.00 710.00 706.00 584.00 1,687.00 1,059.00 622.00 8.00 0.00 194.00
Other Liabilities
1,338.00 1,168.00 998.00 1,006.00 1,078.00 958.00 846.00 777.00 862.00 634.00 651.00 484.00
Total Liabilities
8,151.00 7,556.00 6,399.00 6,130.00 7,074.00 6,643.00 5,879.00 4,549.00 3,678.00 2,509.00 2,182.00 1,511.00
Fixed Assets
2,828.00 2,513.00 2,536.00 2,377.00 1,771.00 1,774.00 1,276.00 1,085.00 918.00 799.00 697.00 489.00
CWIP
683.00 837.00 524.00 601.00 2,304.00 2,183.00 1,570.00 1,107.00 741.00 348.00 92.00 83.00
Investments
271.00 260.00 227.00 229.00 219.00 343.00 833.00 506.00 299.00 103.00 37.00 33.00
Other Assets
4,368.00 3,946.00 3,112.00 2,922.00 2,779.00 2,344.00 2,199.00 1,850.00 1,720.00 1,259.00 1,355.00 906.00
Total Assets
8,151.00 7,556.00 6,399.00 6,130.00 7,074.00 6,643.00 5,879.00 4,549.00 3,678.00 2,509.00 2,182.00 1,511.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
809.00 227.00 773.00 730.00 545.00 1,485.00 540.00 809.00 305.00 327.00 848.00 180.00
Cash from Investing Activity
-483.00 -636.00 -329.00 -461.00 -369.00 -926.00 -822.00 -754.00 -794.00 -511.00 -292.00 -199.00
Cash from Financing Activity
-318.00 404.00 -445.00 -261.00 -217.00 -534.00 166.00 80.00 498.00 -96.00 -276.00 18.00
Net Cash Flow
8.00 -6.00 -2.00 8.00 -40.00 25.00 -116.00 135.00 9.00 -280.00 280.00 -1.00
Free Cash Flow
376.00 -327.00 448.00 287.00 124.00 884.00 -88.00 244.00 -290.00 -119.00 558.00 -21.00
CFO/OP %
83.00 30.00 78.00 118.00 74.00 119.00 61.00 110.00 68.00 70.00 106.00 61.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
88.00 90.00 83.00 85.00 72.00 30.00 69.00 54.00 77.00 57.00 45.00 61.00
Inventory Days
370.00 403.00 274.00 280.00 339.00 376.00 375.00 325.00 274.00 237.00 240.00 195.00
Days Payable
119.00 148.00 126.00 131.00 139.00 148.00 137.00 173.00 246.00 177.00 225.00 162.00
Cash Conversion Cycle
339.00 345.00 232.00 234.00 272.00 258.00 307.00 207.00 105.00 117.00 60.00 95.00
Working Capital Days
89.00 94.00 102.00 85.00 83.00 80.00 58.00 44.00 94.00 82.00 57.00 42.00
ROCE %
12.00 11.00 14.00 7.00 12.00 25.00 27.00 24.00 23.00 32.00 72.00 41.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
69.87
69.74
69.74
69.74
69.68
69.67
69.61
69.61
69.61
69.61
69.61
69.61
FIIs
4.17
4.26
4.23
4.04
3.96
3.94
4.17
3.94
4.32
4.46
4.52
4.51
DIIs
15.93
16.17
16.17
16.30
16.46
16.43
16.05
16.05
15.47
15.39
14.51
14.22
Public
10.00
9.83
9.84
9.92
9.91
9.96
10.17
10.38
10.61
10.54
11.36
11.67
No. of Shareholders
86,796
86,432
87,000
89,969
89,013
91,336
93,944
91,429
74,829
76,567
85,212
89,552
Corporate Actions
17 records
Back to all stocks